Enliven Therapeutics, Inc 10-K for FY2024
Enliven Therapeutics, Inc. (ELVN)
10-K
2025-03-13
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 10-K
Enliven Therapeutics, Inc filed this 10-K on March 13, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $89.02M
- compared with a net loss of $71.58M a year earlier
- Diluted EPS
- -$1.89
- compared with -$2.01 a year earlier